2012 | | Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer | 소의영 |
2012 | | Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients | 김구상 |
2013 | | Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study. | 정용식 |
2018 | | Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer | 정용식 |
2018 | | Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer | 김영배, 우현구, 이다근, 최지혜, 한상욱 |
2016 | | KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients | 정용식 |
2001 | | Methylation of O(6)-methylguanine-DNA methyltransferase gene is associated significantly with K-ras mutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. | 김영배, 백운기, 임인경, 조용관, 한상욱 |
2016 | | MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers | 김영배, 서광욱, 이다근, 이현우, 최용원 |
2021 | | Presence of TERT ± BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma | 김형규, 노진, 이정훈, 하은주 |
2012 | | Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study | 김구상, 정용식 |
2019 | | Proteogenomic Characterization of Human Early-Onset Gastric Cancer | 한상욱 |
2018 | | Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer | 김혁훈, 왕희정, 우현구, 윤사라 |
2015 | | Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer. | 김장희, 소의영, 안영실, 윤준기, 이수진, 정윤석 |
2015 | | Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma. | 김장희, 박태준, 소의영, 이정훈, 최용원 |
2013 | | The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study. | 김구상, 정용식 |
2015 | | VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases. | 김대중, 김장희, 소의영, 신승수, 이기범, 이정훈, 임현이, 정선용, 정윤석, 한재호 |